Unlock stock picks and a broker-level newsfeed that powers Wall Street.

IOB - Delayed Quote EUR

0R9T.IL,0P0000KIJI,37 (0R9T.IL)

50.70

+1.65

+(3.36%)

At close: July 23 at 9:00:00 PM GMT+1

Equasens: 2024 annual results

Villers-lès-Nancy, 28 March 2025 - 6:00 p.m. (CET) PRESS RELEASE 2024 annual results Full-year results adversely affected by difficult economic conditions in H1 combined with continuing investment efforts: Revenue: €216.8m (-1.4%)Current Operating Income: €45.1m (-19.2%) Net profit attributable to Group shareholders: €36.2m (-23.0%) At the same time, profit margins remained high, and even improved over the year: Current operating income / Revenue: 20.8% on a reported basis (H1: 19.3% and H2: 22.

GlobeNewswire 7 days ago

EQS.PA
3 Reliable Dividend Stocks Offering Yields Up To 6.7%

In the face of recent market volatility driven by tariff uncertainties and mixed economic data, investors are increasingly seeking stability through dividend stocks. With their potential to provide consistent income even amid fluctuating markets, these stocks can be a valuable component of a diversified portfolio, especially when global economic conditions appear uncertain.

Simply Wall St. last month

GLPEF

GLPEY

EQS.PA
Equasens: 2024 annual revenue

Villers-lès-Nancy, 6 February 2025 - 6:00 p.m. (CET) PRESS RELEASE 2024 annual revenue: €216.8 million including €58.6 million in Q4 (+2.6% on a reported basis and -0.4% like-for-like) Revenue (€&)2023Reported basis2024Reported basisChange /Reported basisOf which external growthOf which Ségur1 2024Of which Ségur 2023Like-for-like change(organic growth)Q156.253.3-2.9-5.2%2.00.3-1.4-3.8-6.7%Q256.454.7-1.7-3.0%1.70.3-1.2-2.6-4.6%Q350.150.20.10.3%1.80.2-0.3-1.5-3.0%Q457.058.61.52.6%1.70.2-0.3-0.2-0.

GlobeNewswire last month

EQS.PA
Equasens: strategic acquisition of Calimed, a SaaS software expert for private practitioners and surgeons

Villers-lès-Nancy, 27 December 2024 - 6:00 p.m. (CET)PRESS RELEASE Equasens strengthens its presence in the healthcare software market with the strategic acquisition of Calimed, a SaaS software expert for private practitioners and surgeons Equasens Group (Euronext Paris™ - Compartment B - FR 0012882389 -EQS), a leading provider of digital solutions for healthcare professionals, acquires a 90% majority stake in Calimed SAS, a pure player in the market for 100% cloud-based medical Practice Managem

GlobeNewswire 3 months ago

EQS.PA
Top 3 Dividend Stocks To Enhance Your Portfolio

As global markets experience broad-based gains with U.S. indexes approaching record highs, investors are navigating a landscape marked by strong labor market data and stabilizing economic indicators. In this environment, dividend stocks can offer a compelling opportunity for those seeking to enhance their portfolios with steady income streams and potential growth, particularly as interest rates show signs of easing.

Simply Wall St. 4 months ago

SCANFL.HE

EQS.PA

ASOZF
Equasens: 2024 nine-month revenue: €158.2 million - Return to growth in Q3 (+0.3%)

Villers-lès-Nancy, 7 November 2024 - 6:00 p.m. (CET) PRESS RELEASE 2024 nine-month revenue: €158.2 million Return to growth in Q3 (+0.3%) Revenue (€m) 2023Reported basis 2024Reported basis Change /Reported basis - Ségur2024 +Ségur2023 - External Growth Change /Like-for-like basis Q1 56.2 53.3 -2.9 -5.2% 0.3 1.4 2.0 -3.8 -6.7% Q2 56.4 54.7 -1.7 -3.0% 0.3 1.2 1.7 -2.6 -4.6% Q3 50.1 50.2 0.1 0.3% 0.2 0.3 1.8 -1.5 -3.0% Total 162.7 158.2 -4.5 -2.8% 0.9 2.9 5.5 -7.9 -4.9% At September 30, 2024, Equas

GlobeNewswire 4 months ago

EQS.PA
Equasens: 2024 half-year results

Villers-lès-Nancy, 27 September 2024 - 6:00 p.m. (CET) PRESS RELEASE 2024 half-year results Group results impacted by weaker economic conditions and continuing investment efforts in H1: Revenue: €108.0m, -4.1%Current Operating Income: €20.9m, -24.1% Net Profit attributable to the Group: €17.2m, -21.8% Though with a profit margin that continues to be very positive: Ratio of Current Operating Income (COI) to Sales: 19.3% on a reported basis and 20.0% like-for-like H1 RESULTS (€M)2023reported basis

GlobeNewswire 6 months ago

EQS.PA
Equasens: H1 2024 revenue

Villers-lès-Nancy, 2 August 2024 - 6:00 p.m. (CET) PRESS RELEASE H1 2024 revenue: €108 million Contributions from new acquisitions offset the base effect from the Ségur digital healthcare investment programme.The Divisions that sell equipment remain heavily impacted by the economic context. 2024 outlook: The Group expects to return to growth in H2.Profitability in 2024 will be impacted both by the continuation of the Group's investment policy and by unfavourable economic conditions. H1 revenue (

GlobeNewswire 7 months ago

EQS.PA
Equasens: RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 27 JUNE 2024

Villers-lès-Nancy, 5 July 2024 - 6:00 p.m. (CET) PRESS RELEASE RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 27 JUNE 2024 Number of shares comprising the share capital: 15,174,125 Number of shares with voting rights: 15,031,080 Number of shares with voting rights possessed by shareholders presents or represented or having voted by mail: 13,070,268 That means a quorum of 86.95% of the 15,031,080 shares with voting rights: the Ordinary Annual Gen

GlobeNewswire 8 months ago

EQS.PA
Equasens: ANNUAL ORDINARY GENERAL MEETING - MEETING NOTICE - ON-LINE AVAILABILITY OF MEETING MATERIALS

Villers-lès-Nancy, 10 June 2024 - 6:00 p.m. (CET) PRESS RELEASE ANNUAL ORDINARY GENERAL MEETING MEETING NOTICE ON-LINE AVAILABILITY OF MEETING MATERIALS EQUASENS hereby provides notice to shareholders of the Annual Ordinary General Meeting to be held on Thursday, June 27, 2024 at 5.30 pm at the Company’s registered office located in Villers-lès-Nancy (Technopôle de Nancy-Brabois - 5 Allée de Saint Cloud). The original French language version of the agenda and the resolutions submitted by the Boa

GlobeNewswire 9 months ago

EQS.PA
Equasens: Q1 2024 revenue

Villers-lès-Nancy, 7 May 2024 - 6:00 p.m. (CET) PRESS RELEASE Q1 2024 revenue: €53.3 million Contributions from new acquisitions offset the base effect from the Ségur digital healthcare investment programme.The Divisions that sell equipment are heavily impacted by the economic context. 2024 outlook: after a phase of significant investment, the Group is targeting a return to growth beginning in H2. Q1 revenue (€m)2023 reported basis2024 reported basisChange / Reported basis- Ségur2024+Ségur2023-

GlobeNewswire 10 months ago

EQS.PA